Many laboratories involved in drug-abuse screening use enzymoimmunoassays such as Syva's EMIT#{174} system. Although automation has been extensively used to reduce assay costs, further reductions can be achieved by the development of in-house reagents. We have developed our own reagents for the detection of opiates in urine by using the Syva EMIT principle and adapted it for use on an Eppendorf EPOS analyzer. The immunogen was produced from 3-carboxymethylmorphine, and morphine-3-glucuronide attached to glucose-6-ptiosphate dehydrogenase was used as the tracer. Excellent agreement with Syva's commercial assays was obtained. we describe the preparation and development of in-house reagents by using morphine-3-glucuromde linked to glucose-6-phosphate dehydrogenase (G6PDH; EC 1.1.1.49)' as the tracer and antisera prepared from an immunogen comprising 3-carboxymethylmorphine and keyhole limpet hemocyarnn. Using the nonseparation technique pioneered by Syva, we adapted the reagents to run on an Eppendorf EPOS analyzer (8).
Opiates are among the most commonly abused drugs and, because of the associated dangers, their detection is essential in any screening program. Immunoassays for their detection have been available for many years (1-4) with Syva's EMiT#{174} system (1) being widely used.
We had believed that specially designed and matched antisera and enzyme labels were necessary for the EMIT system; this may have been a generally held view, because most publications have concentrated on improvements in cost effectiveness (5, 6) rather than on the system itselL Having previously studied the antisera requirements (7; DL Colbert, J Landon, unpublished observations),
we describe the preparation and development of in-house reagents by using morphine-3-glucuromde linked to glucose-6-phosphate dehydrogenase (G6PDH; EC 1.1.1.49)' as the tracer and antisera prepared from an immunogen comprising 3-carboxymethylmorphine and keyhole limpet hemocyarnn. Using the nonseparation technique pioneered by Syva, we adapted the reagents to run on an Eppendorf EPOS analyzer (8).
MaterIals and Methods

Materials
Morphine-3-glucuronide, G6PDH, fJ-nicotinainide adenine dinucleotide (NAD), N-hydroxysuccinimide (NHS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), and glucose 6-phosphate (G6P) were from Sigma (Poole, Dorset, UK Standard curve. The optimum dilution of one antiserum was used to set up a standard curve on the EPOS analyzer and compared with that achieved by Syva one of thc four was due to dihydrocodeine and three were due t.c codeine. Two samples were negative with Syva reagent but positive for morphine with our reagents. However, al] were close to the cut-off concentration of 0.3 mg/L (0.9 imo1/L).
DIscussIon
It is essential to include the opiates in any screenin program for abused drugs, and broad-spectrum immu noassays are the most useful for their initial detection Furthermore, techniques that can be automated are in valuable when the workload is increasing rapidly. Be cause of the wide range of instruments that can be adapted to use Syva reagents, this has been the technique mosi costs (5,6) . Further savings are possible by preparing in-house reagents.
Earlier studies showed that Syva antisera could be successfully replaced by antisera not designed for that specific use (7; DL Colbert, J Landon, unpublished observations).
To develop an assay for opiates, we used an immunogen prepared from 3-carboxymethylmorphine and prepared a tracer from morphine-3-glucuronide with G6PDH as the label.
The ultimate sensitivity of the Syva system depends on the choice of enzyme and the equipment used for measuring the enzyme reaction rate (1). Since the introduction of these assays, there have been major advances in assay automation; the Eppendorf EPOS analyzer (8) makes it possible to perform 300 assays per hour with high precision.
When the presence of a drug is determined by a reaction being greater than a cut-off value, there will always be cases of disagreement at concentrations close to the cut-off point because of variations such as cross- At the time of writing, the cost of preparing 50 mL stock substrate/co-factor in the United Kingdom was $363. Sufficient working reagent for 100 tests (25 mL) requires 500 ML of stock substrate/co-factor at a cost of $0.03 per assay. This concentration of substrate/cofactor was chosen to give the maximum rate of reaction but proved to be the major cost factor. Halving the concentration to bring it closer to that suggested elsewhere (6) only reduced the rate of reaction by a small amount and, if used, could reduce costs further. The antiserum used was available commercially at a cost equivalent to $27/mL, which would add $0.02 to the cost of each assay. Enzyme costs may vary with efficiency of coupling but, in the example given, a 1000-unit ampule was used, at a cost of $83. Dialyzed enzyme (22 mL) was diluted 1/400 to give 8.800 L of working enzyme reagent. Because 48 pL is used in the assay, the cost is equivalent to $00005 per test. The microcentrifuge tubes cost $0.03 each but can be reused for several different assays. The analyzer uses laundered quartz cuvettes, and a total cost of <$0.10 per assay is a reasonable expectation with these in-house reagents.
Syva's commercial kit, similarly diluted, would cost $0.50 per test.
We originally dialyzed the enzyme tracer against distilled water, but long-term storage proved unsatisfactory. Dialyzing against Ths working assay buffer (pH 8) improved stability, as did storing frozen aliquots, but activity was still gradually lost. Freeze-drying would probably be the best procedure, but excellent stability was achieved by adding 3.2 mol/L anunonium sulphate to the stock enzyme (pH 6). Under these conditions the stock reagent was stable for >6 months and the diluted working reagent for >2 months at 4#{176}C.
We prepared these reagents on three separate occasions, and all batches had similar characteristics and overall performance.
The main differences among the batches were the extent of inactivation and the percentage inhibition in the presence of excess antiserum (7). In general, there was a 20-30% loss of activity during coupling. The batch reported here showed a 45% inhibition of activity in the presence of antiserum, whereas later batches had -40% inhibition. These later batches showed no obvious loss of sensitivity at low concentrations (near the cutoff for a positive result) but there was a gradual flattening of the standard curve at higher concentrations resulting in poorer precision (-6-7%) at 1 mg/L (3.29 mo1JL). However, this had no apparent effect on the ability of the reagent to distinguish between positive and negative samples.
The preparation of in-house reagents seems to be a feasible alternative approach to cost reduction of drugabuse testing.
